Inventor

VAN DEN BRINK EDWARD

NL26 patents

⚠️ This page may combine multiple inventors who share the name “VAN DEN BRINK EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VAN DEN BRINK EDWARD

H LUNDBECK AS

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Antibodies for the treatment of synucleinopathy

Antibodies for the treatment of synucleinopathy

Antibodies for the treatment of synucleinopathy

Antibodies for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Agent, uses and methods for treatment

Anti-sortilin antibodies, uses and methods for treatment

Agent, uses and methods for treatment

Agent, uses and methods for treatment

Agents, uses and methods for treatment

Agent, uses and methods for treatment

GENMAB HOLDING B V

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

Methods of use of anti-CD37 antibodies, monoclonal anti-CD37 antibodies

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

GENMAB AS

Bispecific antibodies against CD3 and CD20

Binding agents binding to PD-L1 and CD137 and use thereof

Binding agents binding to PD-L1 and CD137 and use thereof

GENMAB

Humanized or chimeric CD3 antibodies